Ashley Argiras on scaling quality in a platform biotech

In today’s episode I was joined by Ashley Argiras, VP of Quality at Recursion.

I really wanted to speak to Ashley because she’s helping redefine what quality leadership looks like in a tech-enabled, platform biotech - and she’s doing it by shifting how people think, not just how they work.

Ashley’s journey into science started in high school - not in a lab, but making ice cream during chemistry class. That moment sparked a lifelong curiosity that took her to Indiana University, and eventually into clinical research. She began her career as a CRA at Eli Lilly, where she visited trial sites and became the first line of quality, working hands-on with investigators to ensure patient safety and protocol integrity.

That experience gave her a real-world understanding of what quality means at the ground level, and it’s shaped the way she leads today: rooted in purpose, driven by questions, and always looking for better ways to serve patients.

We talk about the following:

🎙️ How quality supports speed in a platform biotech

🎙️ Ashley’s early career in clinical trials and where it all began

🎙️ Teaching teams to ask better questions, not follow checklists

🎙️ What “inspection ready” really means in a modern organisation

🎙️ Why judgment and empowerment are better than policy and policing

🎙️ How Ashley thinks about org structure during scale-up

🎙️ Leading with listening (and learning to talk less as a VP)

🎙️ Avoiding the bottleneck trap as a quality leader

🎙️ Building a safe space for decisions - even if they’re wrong

🎙️ Lessons in growing from tactical QA to strategic leadership

Ashley is a sharp, thoughtful leader proving that real quality leadership starts with having the right mindset.

Thank you, Ashley, for sharing your incredible journey.

Hope everyone enjoys the show!